|
Research and development activities with GMO-medicinal products
(Last revised:
February 3, 2009
)

Gene
Therapy clinical trials in humans
Regulatory framework for gene therapy clinical trials or clinical trials with a medicinal product involving a genetically modified organism in Belgium (11 May 2005)
Competent
authorities (15 January 2005)
Current procedural aspects for the authorisation of gene therapy clinical trials in Belgium (11 May 2005)
Approved gene therapy clinical trials in Belgium (18 August 2008)
Guidelines to compile the Information for the public in case of deliberate release of the GMO: explanations and PDF file
Gelsinger case and impact in Belgium (1 June 2001)
Specific guidelines on gene therapy in the world (25 January 2006)
Specific guidelines on stem cells, cell therapy and xenotransplantation in the world (25 January 2006)
Hot Links (26 January 2006)
Clinical
trials with GMO-veterinary vaccines
Regulatory framework for clinical trials with GMO-veterinary vaccines (11 May 2005)
Competent
authorities (11 May 2005)
Specific guidelines on live recombinant vector vaccines (1 February 2005)
Deliberate
releases of GMO-medicinal products (humans and veterinary) in Belgium
Deliberate releases of GMO-medicinal products in Belgium since 1997 (Database)
Guidelines to compile the Information for the public in case of deliberate release of the GMO: explanations and PDF file
|